Treat-to-Target Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Comparator) in Basal Therapy for Patients With Type 2 Diabetes Mellitus.
Latest Information Update: 27 Jun 2012
At a glance
- Drugs Insulin lispro (Primary) ; Insulin detemir
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms COMPLETE T2D
- Sponsors Eli Lilly and Company
- 13 May 2011 New source identified and integrated (European Clinical Trials Database; EudraCT2007-002150-39).
- 10 Nov 2009 Actual patient number changed from 377 to 442 as reported by ClinicalTrials.gov.
- 02 Oct 2008 Status changed from active, no longer recruiting to completed according to the ClinicalTrials.gov record.